Steve Scala
Stock Analyst at TD Cowen
(4.46)
# 1,099
Out of 4,463 analysts
391
Total ratings
63.2%
Success rate
10.6%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Rated: Buy | $150 → $104 | $72.45 | +43.55% | 24 | Jun 30, 2026 | |
| SNY Sanofi | Maintained: Hold | $57 | $41.63 | +36.92% | 25 | Jun 29, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $24 → $32 | $24.09 | +32.84% | 17 | Jun 18, 2026 | |
| GSK GSK plc | Maintained: Hold | $70 | $51.30 | +36.45% | 29 | Jun 11, 2026 | |
| NVS Novartis AG | Maintained: Hold | $148 → $180 | $154.14 | +16.78% | 34 | Jun 11, 2026 | |
| NVAX Novavax | Rated: Hold | $8 → $9 | $9.46 | -4.86% | 5 | May 6, 2026 | |
| PFE Pfizer | Maintained: Hold | $30 | $23.88 | +25.63% | 43 | May 6, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | n/a | $13,854.00 | - | 8 | Apr 30, 2026 | |
| RHHBY Roche Holding AG | Maintained: Hold | $67 | $50.59 | +32.44% | 27 | Apr 23, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,250 | $1,191.74 | +4.89% | 47 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $120 → $137 | $125.37 | +9.28% | 31 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 | $251.06 | +11.53% | 39 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $54 | $56.44 | -4.32% | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $15 | $13.53 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17.06 | $6.99 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $55.78 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.22 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.70 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 96.59 → CHF 109.47 | $125.00 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $48.77 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 1,054 | $324.00 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,250p → 1,790p | $1,930.00 | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | $328.80 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €42.09 → €98.00 | $73.05 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.73 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €68.39 → €75.41 | $144.50 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $361.33 | n/a | 2 | Oct 3, 2017 |
Zoetis
Jun 30, 2026
Rated: Buy
Price Target: $150 → $104
Current: $72.45
Upside: +43.55%
Sanofi
Jun 29, 2026
Maintained: Hold
Price Target: $57
Current: $41.63
Upside: +36.92%
Elanco Animal Health
Jun 18, 2026
Rated: Buy
Price Target: $24 → $32
Current: $24.09
Upside: +32.84%
GSK plc
Jun 11, 2026
Maintained: Hold
Price Target: $70
Current: $51.30
Upside: +36.45%
Novartis AG
Jun 11, 2026
Maintained: Hold
Price Target: $148 → $180
Current: $154.14
Upside: +16.78%
Novavax
May 6, 2026
Rated: Hold
Price Target: $8 → $9
Current: $9.46
Upside: -4.86%
Pfizer
May 6, 2026
Maintained: Hold
Price Target: $30
Current: $23.88
Upside: +25.63%
AstraZeneca PLC
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $13,854.00
Upside: -
Roche Holding AG
Apr 23, 2026
Maintained: Hold
Price Target: $67
Current: $50.59
Upside: +32.44%
Eli Lilly and Company
Apr 2, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,191.74
Upside: +4.89%
Mar 30, 2026
Maintained: Hold
Price Target: $120 → $137
Current: $125.37
Upside: +9.28%
Feb 4, 2026
Maintained: Buy
Price Target: $280
Current: $251.06
Upside: +11.53%
Jul 31, 2025
Maintained: Hold
Price Target: $64 → $54
Current: $56.44
Upside: -4.32%
Apr 22, 2025
Maintained: Hold
Price Target: $19 → $15
Current: $13.53
Upside: n/a
Feb 21, 2025
Maintained: Hold
Price Target: $17.06
Current: $6.99
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $55.78
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.22
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.70
Upside: n/a
Nov 11, 2024
Maintained: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: $125.00
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $48.77
Upside: n/a
Mar 11, 2024
Maintained: Buy
Price Target: kr 1,054
Current: $324.00
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: 2,250p → 1,790p
Current: $1,930.00
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: $328.80
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €42.09 → €98.00
Current: $73.05
Upside: n/a
Jun 24, 2021
Maintained: Buy
Price Target: n/a
Current: $4.73
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €68.39 → €75.41
Current: $144.50
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $361.33
Upside: n/a